Stereotactic Body Radiotherapy for the Treatment of OPD
NCT03256981
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
113
Enrollment
OTHER
Sponsor class
Conditions
NSCLC
Interventions
RADIATION:
SBRT
DRUG:
TKI
Sponsor
Institute of Cancer Research, United Kingdom